JAGX vs. SCYX, DTIL, ESLA, VTVT, CLNN, RAPT, CALC, CASI, TPST, and LTRN
Should you be buying Jaguar Health stock or one of its competitors? The main competitors of Jaguar Health include SCYNEXIS (SCYX), Precision BioSciences (DTIL), Estrella Immunopharma (ESLA), vTv Therapeutics (VTVT), Clene (CLNN), RAPT Therapeutics (RAPT), CalciMedica (CALC), CASI Pharmaceuticals (CASI), Tempest Therapeutics (TPST), and Lantern Pharma (LTRN). These companies are all part of the "pharmaceutical products" industry.
Jaguar Health vs.
Jaguar Health (NASDAQ:JAGX) and SCYNEXIS (NASDAQ:SCYX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, valuation, dividends, profitability, earnings, analyst recommendations and risk.
12.0% of Jaguar Health shares are owned by institutional investors. Comparatively, 54.4% of SCYNEXIS shares are owned by institutional investors. 0.0% of Jaguar Health shares are owned by insiders. Comparatively, 2.9% of SCYNEXIS shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
SCYNEXIS has higher revenue and earnings than Jaguar Health.
Jaguar Health received 1330 more outperform votes than SCYNEXIS when rated by MarketBeat users. Likewise, 88.73% of users gave Jaguar Health an outperform vote while only 70.04% of users gave SCYNEXIS an outperform vote.
In the previous week, Jaguar Health had 1 more articles in the media than SCYNEXIS. MarketBeat recorded 1 mentions for Jaguar Health and 0 mentions for SCYNEXIS. Jaguar Health's average media sentiment score of 0.50 beat SCYNEXIS's score of 0.00 indicating that Jaguar Health is being referred to more favorably in the media.
Jaguar Health has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Comparatively, SCYNEXIS has a beta of 1.53, suggesting that its share price is 53% more volatile than the S&P 500.
Jaguar Health has a net margin of -360.13% compared to SCYNEXIS's net margin of -425.41%. SCYNEXIS's return on equity of -66.21% beat Jaguar Health's return on equity.
Summary
SCYNEXIS beats Jaguar Health on 9 of the 15 factors compared between the two stocks.
Get Jaguar Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Jaguar Health Competitors List
Related Companies and Tools
This page (NASDAQ:JAGX) was last updated on 1/21/2025 by MarketBeat.com Staff
Free JAGX Stock Alerts